Partial long-term clinical improvement after a BCG challenge in systemic lupus erythematosus-prone mice

References

• Pan L, Lu MP, Wang JH, et al. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19–30. doi: 10.1007/s12519-019-00229-3
   PubMed Web of Science ®Google Scholar
• Fortuna G, Brennan MT. Systemic lupus erythematosus. Dent Clin North Am. 2013;57(4):631–655. doi: 10.1016/j.cden.2013.06.003
   PubMedGoogle Scholar
• Ahmad HI, Jabbar A, Mushtaq N, et al. Immune tolerance vs. immune resistance: the Interaction between host and pathogens in infectious diseases. Front Vet Sci. 2022;9:827407. doi: 10.3389/fvets.2022.827407
   Google Scholar
• Di Bartolomeo S, Alunno A, Carubbi F. Respiratory manifestations in systemic lupus erythematosus. Pharmaceuticals. 2021;14(3):276. doi: 10.3390/ph14030276
   Google Scholar
• Mora VP, Loaiza RA, Soto JA, et al. Involvement of trained immunity during autoimmune responses. J Autoimmun. 2023;137:102956. https://linkinghub.elsevier.com/retrieve/pii/S0896841122001640. doi: 10.1016/j.jaut.2022.102956
   Google Scholar
• Tamirou F, Houssiau FA. Management of lupus nephritis. J Clin Med. 2021;10(4):670. doi: 10.3390/jcm10040670
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Lo MS, Reis PC, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–730. doi: 10.1038/nrrheum.2016.186
   PubMed Web of Science ®Google Scholar
• Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–532. doi: 10.1038/s41584-021-00668-1
   PubMed Web of Science ®Google Scholar
• Mahajan A, Herrmann M, Muñoz LE. Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE. Front Immunol. 2016;7:35. doi: 10.3389/fimmu.2016.00035
   PubMed Web of Science ®Google Scholar
• Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605–614. doi: 10.1038/s41590-020-0677-6
   PubMed Web of Science ®Google Scholar
• Mackern‐Oberti JP, Llanos C, Riedel CA, et al. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus. Immunology. 2015;146(4):497–507. doi: 10.1111/imm.12504
   Google Scholar
• Yu Y, Su K. Neutrophil extracellular traps and systemic lupus erythematosus. J Clin Cell Immunol. 2013;4(02):1–13. doi: 10.4172/2155-9899.1000139
   Google Scholar
• Mackern-Oberti JP, Jara EL, Riedel CA, et al. Hormonal modulation of dendritic cells differentiation, maturation and function: implications for the initiation and progress of systemic autoimmunity. Arch Immunol Ther Exp. 2017;65(2):123–136. doi: 10.1007/s00005-016-0418-6
   Google Scholar
• Mackern-Oberti JP, Llanos C, Vega F, et al. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases. Autoimmun Rev. 2015;14(2):127–139. doi: 10.1016/j.autrev.2014.10.010
   PubMed Web of Science ®Google Scholar
• Carreño LJ, Pacheco R, Gutierrez MA, et al. Disease activity in systemic lupus erythematosus is associated with an altered expression of low‐affinity Fcγ receptors and costimulatory molecules on dendritic cells. Immunology. 2009;128(3):334–341. doi: 10.1111/j.1365-2567.2009.03138.x
   PubMed Web of Science ®Google Scholar
• Alarcón-Riquelme ME. The heterogeneity of systemic lupus erythematosus: looking for a molecular answer. Revista Colombiana de Reumatología. 2021;28:31–38. doi: 10.1016/j.rcreu.2021.02.006
   Google Scholar
• Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15–29. doi: 10.1136/ard-2023-224762
   Web of Science ®Google Scholar
• Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res . 2012;64(6):797–808. doi: 10.1002/acr.21664
   PubMed Web of Science ®Google Scholar
• Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–1460. doi: 10.1001/jamaophthalmol.2014.3459
   PubMed Web of Science ®Google Scholar
• Suzuki K, Tanaka Y. Infections associated with systemic lupus erythematosus: tackling two devils in the Deep Blue Sea. Indian J Rheumatol. 2023;18(Suppl 1):S3–S11. doi: 10.4103/injr.injr_78_22
   Google Scholar
• Singh JA, Shah NP, Mudano AS, . Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021;2021(2):1–39. doi: 10.1002/14651858.CD010668.pub2
   Google Scholar
• Atisha‐Fregoso Y, Malkiel S, Harris KM, et al. Phase II randomized trial of rituximab Plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis. Arthritis Rheumatol. 2021;73(1):121–131. doi: 10.1002/art.41466
   PubMed Web of Science ®Google Scholar
• Mendoza-Pinto C, Etchegaray-Morales I, Ugarte-Gil MF. Improving access to SLE therapies in low and middle-income countries. Rheumatology . 2023;62(Suppl 1):i30–i35. doi: 10.1093/rheumatology/keac530
   Google Scholar
• Mackensen A, Müller F, Mougiakakos D, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28(10):2124–2132. doi: 10.1038/s41591-022-02017-5
   PubMed Web of Science ®Google Scholar
• Obreque J, Vega F, Torres A, et al. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype. Immunology. 2017;152(4):648–659. doi: 10.1111/imm.12806
   Google Scholar
• Funes SC, Ríos M, Gómez‐Santander F, et al. Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice. Immunology. 2019;158(4):322–339. doi: 10.1111/imm.13119
   Google Scholar
• Llanos C, Mackern-Oberti JP, Vega F, et al. Tolerogenic dendritic cells as a therapy for treating lupus. Clin Immunol. 2013;148(2):237–245. doi: 10.1016/j.clim.2013.04.017
   Google Scholar
• Covián C, Fernández-Fierro A, Retamal-Díaz A, et al. BCG-induced cross-protection and development of trained immunity: implication for vaccine design. Front Immunol. 2019;10:2806. doi: 10.3389/fimmu.2019.02806
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Fernández-Fierro A, et al. Trained immunity contribution to autoimmune and inflammatory disorders. Front Immunol. 2022;13:868343. doi: 10.3389/fimmu.2022.868343
   Google Scholar
• Soto JA, Gálvez NMS, Andrade CA, et al. BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Trends Immunol. 2022;43(4):322–335. doi: 10.1016/j.it.2021.12.006
   Google Scholar
• Covián C, Ríos M, Berríos-Rojas RV, et al. Induction of trained immunity by recombinant vaccines. Front Immunol. 2020;11:611946. doi: 10.3389/fimmu.2020.611946
   Google Scholar
• Hsu T, Hingley-Wilson SM, Chen B, et al. The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A. 2003;100(21):12420–12425. doi: 10.1073/pnas.1635213100
   PubMed Web of Science ®Google Scholar
• Kalyn Eadie. The effect of Mycobacterium bovis-BCG infection on longevity and autoimmune disease in MRL/lpr mic. ; 2004 [Montreal]McGiII University;.
   Google Scholar
• Shpilsky GF, Takahashi H, Aristarkhova A, et al. Bacillus Calmette-Guerin ‘s beneficial impact on glucose metabolism: evidence for broad based applications. iScience. 2021;24(10):103150. doi: 10.1016/j.isci.2021.103150
   PubMed Web of Science ®Google Scholar
• Mao C, Xu X, Ding Y, et al. Optimization of BCG therapy targeting neutrophil extracellular traps, autophagy, and mirnas in bladder cancer: implications for personalized medicine. Front Med . 2021;8:735590. doi: 10.3389/fmed.2021.735590
   Google Scholar
• Ristori G, Romano S, Cannoni S, et al. Effects of bacille Calmette-Guérin after the first demyelinating event in the CNS. Neurology. 2014;82(1):41–48. doi: 10.1212/01.wnl.0000438216.93319.ab
   PubMed Web of Science ®Google Scholar
• Matsuzaki G, Teruya N, Kiyohara Kohama H, et al. Mycobacterium bovis BCG-mediated suppression of Th17 response in mouse experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol. 2021;43(2):203–211. doi: 10.1080/08923973.2021.1878215
   PubMed Web of Science ®Google Scholar
• Kühtreiber WM, Tran L, Kim T, et al. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. Npj Vaccines. 2018;3(1):23. doi: 10.1038/s41541-018-0062-8
   PubMed Web of Science ®Google Scholar
• Faustman DL. TNF, TNF inducers, and TNFR2 agonists: a new path to type 1 diabetes treatment. Diabetes Metab Res Rev. 2018;34(1):1–6. doi: 10.1002/dmrr.2941
   Google Scholar
• Baxter AG, Horsfall AC, Healey D, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 1994;83(2):227–231.
   Google Scholar
• Silveira PA, Baxter AG. The NOD mouse as a model of SLE. Autoimmunity. 2001;34(1):53–64. doi: 10.3109/08916930108994126
   PubMed Web of Science ®Google Scholar
• Eadie K. The effect of Mycobacterium bovis-BCG infection on longevity and autoimmune disease in MRL/lpr mice. ; 2004 [Montreal]: mcGiII University;.
   Google Scholar
• Biao YUC, Jiang R, Niu Y y, et al. Therapeutic action research of bacille calmette guerin (BCG) on a systemic lupus erythematosus mouse model. J Immunol Tech Infect Dis. 2016;05(04):4–7. doi: 10.4172/2329-9541.1000150
   Google Scholar
• Richard ML, Gilkeson G. Mouse models of lupus: what they tell us and what they don’t. Lupus Sci Med. 2018;5(1):e000199. doi: 10.1136/lupus-2016-000199
   PubMed Web of Science ®Google Scholar
• Engleman EG, Sonnenfeld G, Dauphinee M, et al. Treatment of NZB/NZW F 1 hybrid mice with Mycobacterium Bovis strain BCG or Type II interferon preparations accelerates autoimmune disease. Arthritis Rheum. 1981;24(11):1396–1402. doi: 10.1002/art.1780241110
   Google Scholar
• Hart DA, Krause G, Martin L, et al. Influence of biological response modifiers of bacterial origin on disease progression in the MRL-lpr model of systemic lupus erythematosus. Clin Invest Med. 1991;14(1):55–62.
   Google Scholar
• Li J, Lu J, Wang G, et al. Past, present and future of bacillus calmette-Guérin vaccine use in China. Vaccines . 2022;10(7):1157. doi: 10.3390/vaccines10071157
   Web of Science ®Google Scholar
• Asadian M, Hassanzadeh SM, Safarchi A, et al. Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2. BMC Genomics. 2022;23(1):609. doi: 10.1186/s12864-022-08826-9
   Google Scholar
• Kalergis AM, Iruretagoyena MI, Barrientos MJ, et al. Modulation of nuclear factor‐κB activity can influence the susceptibility to systemic lupus erythematosus. Immunology. 2009;128(1 Suppl):e306–e314. doi: 10.1111/j.1365-2567.2008.02964.x
   Google Scholar
• Soto JA, Melo-González F, Riedel CA, et al. Modulation of immune cells as a therapy for cutaneous lupus erythematosus. Int J Mol Sci. 2022;23(18):10706. doi: 10.3390/ijms231810706
   Google Scholar
• Sawada T, Fujimori D, Yamamoto Y. Systemic lupus erythematosus and immunodeficiency. Immunol Med. 2019;42(1):1–9. doi: 10.1080/25785826.2019.1628466
   PubMedGoogle Scholar
• Pieterse E, Van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol. 2014;5:164. doi: 10.3389/fimmu.2014.00164
   PubMed Web of Science ®Google Scholar
• Sterner RM, Hartono SP, Grande JP. The pathogenesis of lupus nephritis. J Clin Cell Immunol. 2014;5(2):1–8. doi: 10.4172/2155-9899.1000205
   Google Scholar
• Corapi KM, Dooley MA, Pendergraft WF. Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials. Arthritis Res Ther. 2015;17(1):110. doi: 10.1186/s13075-015-0621-6
   Google Scholar
• Ruiz-Irastorza G, Bertsias G. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatology . 2020;59(Suppl5):v69–v81. doi: 10.1093/rheumatology/keaa403
   PubMedGoogle Scholar
• Soto JA, Díaz FE, Retamal-Díaz A, et al. BCG-based vaccines elicit antigen-specific adaptive and trained immunity against SARS-CoV-2 and andes orthohantavirus. Vaccines. 2022;10(5):721. doi: 10.3390/vaccines10050721
   Google Scholar
• Canedo-Marroquín G, Soto JA, Andrade CA, et al. Increased heme oxygenase 1 expression upon a primary exposure to the respiratory syncytial virus and a secondary mycobacterium bovis infection. Antioxidants. 2022;11(8):1453. doi: 10.3390/antiox11081453
   Google Scholar
• Pacheco GA, Andrade CA, Gálvez NMS, et al. Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults. Front Immunol. 2023;14:1215893. doi: 10.3389/fimmu.2023.1215893
   Google Scholar
• Allen HF, Klingensmith GJ, Jensen P, et al. Effect of bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care. 1999;22(10):1703–1707. doi: 10.2337/diacare.22.10.1703
   PubMed Web of Science ®Google Scholar
• Castro AP, Esaguy N, Aguas AP. Effect of mycobacterial infection in the lupus-prone MRL/lpr Mice: enhancement of life span of autoimmune mice, amelioration of kidney disease and transient decrease in host resistance. Autoimmunity. 1993;16(3):159–166. doi: 10.3109/08916939308993323
   PubMed Web of Science ®Google Scholar
• Malvar A, Pirruccio P, Alberton V, et al. Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant. 2017;32(8):1338–1344. doi: 10.1093/ndt/gfv296
   PubMed Web of Science ®Google Scholar
• Zickert A, Sundelin B, Svenungsson E, et al. Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med. 2014;1(1):e000018. doi: 10.1136/lupus-2014-000018
   PubMedGoogle Scholar
• Aranow C, Zhou D, Diamond B. Anti-DNA antibodies: structure, regulation and pathogenicity. Editor: Robert G. Lahita, Systemic Lupus Erythematosus. Elsevier; 2011.235–258. doi: 10.1016/B978-0-12-374994-9.10014-2.
   Google Scholar
• Wener MH. Immune complexes in systemic lupus erythematosus. Editor: George C. Tsokos, Systemic Lupus Erythematosus. Elsevier. 2016;:223–229. doi: 10.1016/B978-0-12-801917-7.00026-7.
   Google Scholar
• Liu X, Qi Y, Zhao Y, et al. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients. Ren Fail. 2023;1:45.
   Google Scholar
• Pavan Kumar N, Padmapriyadarsini C, Rajamanickam A, et al. Effect of BCG vaccination on proinflammatory responses in elderly individuals. Sci Adv. 2021;7(32):1–9. doi: 10.1126/sciadv.abg7181
   Google Scholar
• Vitales-Noyola M, Oceguera-Maldonado B, Niño-Moreno P, et al. Patients with systemic lupus erythematosus show increased levels and defective function of CD69 + T regulatory cells. Mediators Inflamm. 2017;2017:2513829–2513829. doi: 10.1155/2017/2513829
   Google Scholar
• Peixoto TV, Carrasco S, Botte DAC, et al. CD4 + CD69+ T cells and CD4 + CD25 + FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice. Adv Rheumatol. 2019;59(1):30. doi: 10.1186/s42358-019-0072-x
   PubMedGoogle Scholar
• Crispin JC, Martínez A, de Pablo P, et al. Participation of the CD69 antigen in the T‐cell activation process of Patients with systemic lupus erythematosus. Scand J Immunol. 1998;48(2):196–200. doi: 10.1046/j.1365-3083.1998.00366.x
   Google Scholar
• Pérez-Lara JC, Espinosa E, Santos-Argumedo L, et al. CD38 Correlates with an immunosuppressive Treg phenotype in lupus-prone mice. Int J Mol Sci. 2021;22(21):11977. doi: 10.3390/ijms222111977
   Google Scholar
• Ishikawa S, Akakura S, Abe M, et al. A subset of CD4+ t cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance. J Immunol. 1998;161(3):1267–1273. doi: 10.4049/jimmunol.161.3.1267
   Google Scholar
• Gupta N, Garg S, Vedi S, et al. Future path toward TB vaccine development: boosting BCG or re-educating by a new subunit vaccine. Front Immunol. 2018;9:2371. doi: 10.3389/fimmu.2018.02371
   PubMed Web of Science ®Google Scholar